Client News

CEVEC and Rznomics sign license agreement for the use of CAP® Technology in manufacturing of adenoviral vectors

CENTOGENE GmbH: CENTOGENE Receives FDA Emergency Use Authorization for SARS-CoV-2 RT-PCR Assay for Individuals Without Symptoms or Other Reasons to Suspect COVID-19

Media Advisory: BIO-Europe® Digital | October 26–29, 2020 | European Standard Time

Topas Therapeutics Raises €22 Million (~USD 26 Million) in Series B Financing

Topas Therapeutics Appoints Klaus Martin, Ph.D. as Chief Executive Officer

CENTOGENE GmbH: Kooperation zwischen CENTOGENE und U-Diagnostics verstärkt COVID-19 Testkapazitäten in den Niederlanden

CENTOGENE GmbH: Collaboration Between CENTOGENE and U-Diagnostics Increases COVID-19 Testing Capacities in the Netherlands Information Security Management System Awarded ISO/IEC 27001:2017 Accreditation

Rentschler Biopharma SE: Rentschler Biopharma and ATUM announce Leap-In Transposase® licensing agreement for development of robust manufacturing processes for complex therapeutic proteins

France Biotech: HealthTech For Care and EIT Health Announce the Success of the HealthTech Innovation Days’ Second Edition

Apogenix Advances Clinical Development of CD95L Inhibitor Asunercept in European COVID-19 Phase II Trial